In addition, the response of CANX, BID, NAMPT, and BIRC5 with different expression levels to immune checkpoint inhibitors was predicted based on Tumor Immune Dysfunction and Exclusion (TIDE) algorithm (Figures 8B–H). This evidence concerns the gene NAMPT and neoplasm.